Proteolytic cleavage of protein tyrosine phosphatase μ regulates glioblastoma cell migration

Cancer Research

Volumn 69, Issue 17, 2009, Pages 6960-6968

  Burgoyne, Adam M ^a   Phillips Mason, Polly J ^a   Burden Gulley, Susan M ^a   Robinson, Shenandoah ^a   Sloan, Andrew E ^a   Miller, Robert H ^a   Brady Kalnay, Susann M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE MU; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CELL MIGRATION; CELL NUCLEUS; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM NEOPLASMS; DOWN-REGULATION; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; HYDROLYSIS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PEPTIDE FRAGMENTS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; RNA, MESSENGER;

EID: 70149096641     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0863     Document Type: Article

References (49)

1. Louis DN. Molecular pathology of malignant gliomas. Annu Rev Pathol 2006;1:97-117.
2. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008;359:492-507.
3. Furnari FB, Fenton T, Bachoo RM, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007;21:26 83-710. (Pubitemid 350070717)
4. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. World Health Organization classification of tumours of the nervous system. 4th ed. Lyon: IARC; 2007.
5. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol 2007;170:1445-1453 (Pubitemid 47339290)
6. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME. Molecular targets of glioma invasion. Cell Mol Life Sci 2007;64:458-478
7. Sathornsumetee S, Rich JN. Designer therapies for glioblastoma multiforme. Ann N Y Acad Sci 2008;1142:108-132
8. Burgoyne AM, Palomo JM, Phillips-Mason PJ, et al. PTPμ suppresses glioma cell migration and dispersal. Neuro-oncol 2009. Epub ahead of print, March 20, 2009.
9. Gebbink MF, Zondag GC, Wubbolts RW, Beijersbergen RL, van Etten I, Moolenaar WH. Cell-cell adhesion mediated by a receptor-like protein tyrosine phosphatase. J Biol Chem 1993;268:16101-16104 (Pubitemid 23229902)
10. Brady-Kalnay SM, Flint AJ, Tonks NK. Homophilic binding of PTPμ a receptor-type protein tyrosine phosphatase, can mediate cell-cell aggregation. J Cell Biol 1993;122:961-972 (Pubitemid 23241105)
11. Brady-Kalnay SM, Tonks NK. Identification of the homophilic binding site of the receptor protein tyrosine phosphatase PTPμ. J Biol Chem 1994;269:28472-28477 (Pubitemid 24354594)
12. Ensslen-Craig SE, Brady-Kalnay SM. Receptor protein tyrosine phosphatases regulate neural development and axon guidance. Dev Biol 2004;275:12-22.
13. Sallee JL, Wittchen ES, Burridge K. Regulation of cell adhesion by protein-tyrosine phosphatases. II. Cell-cell adhesion. J Biol Chem 2006;281:16189-16192 (Pubitemid 43909565)
14. Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 2006;7:833-846 (Pubitemid 44627477)
15. Ostman A, Hellberg C, Bohmer FD. Protein-tyrosine phosphatases and cancer. Nat Rev Cancer 2006;6:307-320
16. Aricescu AR, Siebold C, Jones EY. Receptor protein tyrosine phosphatase A: measuring where to stick. Biochem Soc Trans 2008;36:167-172 (Pubitemid 351570586)
17. Alonso A, Sasin J, Bottini N, et al. Protein tyrosine phosphatases in the human genome. Cell 2004;117:699-711. (Pubitemid 38748887)
18. Tiganis T, Bennett AM. Protein tyrosine phosphatase function: the substrate perspective. Biochem J 2007;402:1-15. (Pubitemid 46254902)
19. Xie Y, Massa SM, Ensslen-Craig SE, et al. Protein-tyrosine phosphatase (PTP) wedge domain peptides: a novel approach for inhibition of PTP function and augmentation of protein-tyrosine kinase function. J Biol Chem 2006;281:16482-16492 (Pubitemid 43909599)
20. Oblander SA, Ensslen-Craig SE, Longo FM, Brady- Kalnay SM. E-cadherin promotes retinal ganglion cell neurite outgrowth in a protein tyrosine phosphatase- A-dependent manner. Mol Cell Neurosci 2007;34:481-492
21. Campan M, Yoshizumi M, Seidah NG, Lee ME, Bianchi C, Haber E. Increased proteolytic processing of protein tyrosine phosphatase μ in confluent vascular endothelial cells: the role of PC5, a member of the subtilisin family. Biochemistry 1996;35:3797-3802 (Pubitemid 26102169)
22. Gebbink MF, Zondag GC, Koningstein GM, Feiken E, Wubbolts RW, Moolenaar WH. Cell surface expression of receptor protein tyrosine phosphatase RPTPμ is regulated by cell-cell contact. J Cell Biol 1995;131:251-260
23. Anders L, Mertins P, Lammich S, et al. Furin-, ADAM 10-, and γ-secretase-mediated cleavage of a receptor tyrosine phosphatase and regulation of β-catenin's transcriptional activity. Mol Cell Biol 2006;26:3917-3934
24. Phillips-Mason PJ, Mourton T, Major DL, Brady- Kalnay SM. BCCIP associates with the receptor protein tyrosine phosphatase PTPμ. J Cell Biochem 2008;105:1059-1072
25. Tyminski E, Leroy S, Terada K, et al. Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan. Cancer Res 2005;65:6850-6857 (Pubitemid 41060724)
26. Gebbink MF, van Etten I, Hateboer G, et al. Cloning, expression and chromosomal localization of a new putative receptor-like protein tyrosine phosphatase. FEBS Lett 1991;290:123-130
27. Hellberg CB, Burden-Gulley SM, Pietz GE, Brady- Kalnay SM. Expression of the receptor protein-tyrosine phosphatase, PTPμ, restores E-cadherin-dependent adhesion in human prostate carcinoma cells. J Biol Chem 2002;277:11165-11173
28. Brady-Kalnay SM, Tonks NK. Purification and characterization of the human protein tyrosine phosphatase, PTPμ, from a baculovirus expression system. Mol Cell Biochem 1993;127-8:131-141 (Pubitemid 24032659)
29. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006;1:2315-2319
30. Yu J, Becka S, Zhang P, Zhang X, Brady-Kalnay SM, Wang Z. Tumor-derived extracellular mutations of PTPRT/PTPρ are defective in cell adhesion. Mol Cancer Res 2008;6:1106-1113
31. Chow JP, Fujikawa A, Shimizu H, Suzuki R, Noda M. Metalloproteinase- and γ-secretase-mediated cleavage of protein-tyrosine phosphatase receptor type Z. J Biol Chem 2008;283:30879-30889
32. Haapasalo A, Kim DY, Carey BW, Turunen MK, Pettingell WH, Kovacs DM. Presenilin/γ-secretase-mediated cleavage regulates association of leukocytecommon antigen-related (LAR) receptor tyrosine phosphatase with h-catenin. J Biol Chem 2007;282:9063-9072 (Pubitemid 47093475)
33. Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 2003;3:489-501.
34. Kopan R, Schroeter EH, Weintraub H, Nye JS. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci U S A 1996;93:1683-1688 (Pubitemid 26075185)
35. Brady-Kalnay SM, Rimm DL, Tonks NK. Receptor protein tyrosine phosphatase PTPμ associates with cadherins and catenins in vivo. J Cell Biol 1995;130:977-986
36. Roy M, Pear WS, Aster JC. The multifaceted role of Notch in cancer. Curr Opin Genet Dev 2007;17:52-59
37. Shih IeM, Wang TL. Notch signaling, γ-secretase inhibitors, and cancer therapy. Cancer Res 2007;67:1879-1882
38. Brady-Kalnay SM, Mourton T, Nixon JP, et al. Dynamic interaction of PTPμ with multiple cadherins in vivo. J Cell Biol 1998;141:287-296 (Pubitemid 28182659)
39. Sui XF, Kiser TD, Hyun SW, et al. Receptor protein tyrosine phosphatase μ regulates the paracellular pathway in human lung microvascular endothelia. Am J Pathol 2005;166:1247-1258
40. Hiscox S, Jiang WG. Association of PTPμ with catenins in cancer cells: a possible role for E-cadherin. Int J Oncol 1998;13:1077-1080 (Pubitemid 28506080)
41. Zondag GC, Reynolds AB, Moolenaar WH. Receptor protein-tyrosine phosphatase RPTPμ binds to and dephosphorylates the catenin p120(ctn). J Biol Chem 2000;275:11264-11269 (Pubitemid 30212773)
42. van Hengel J, van Roy F. Diverse functions of p120ctn in tumors. Biochim Biophys Acta 2007;1773:78-88.
43. Daniel JM, Reynolds AB. The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 1999;19:3614-3623 (Pubitemid 29193821)
44. Ferber EC, Kajita M, Wadlow A, et al. A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus. J Biol Chem 2008;283:12691-12700
45. Uemura K, Kihara T, Kuzuya A, et al. Characterization of sequential N-cadherin cleavage by ADAM10 and PS1. Neurosci Lett 2006;402:278-283 (Pubitemid 43850164)
46. Kouchi Z, Barthet G, Serban G, Georgakopoulos A, Shioi J, Robakis NK. p120 catenin recruits cadherins to γ-secretase and inhibits production of Aβ peptide. J Biol Chem 2009;284:1954-1961
47. Kelly KF, Spring CM, Otchere AA, Daniel JM. NLS-dependent nuclear localization of p120ctn is necessary to relieve Kaiso-mediated transcriptional repression. J Cell Sci 2004;117:2675-2686
48. Ono T, Kitaura H, Ugai H, et al. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase. J Biol Chem 2000;275:31145-31154 (Pubitemid 30757775)
49. Audhya A, Emr SD. Regulation of PI4,5P2 synthesis by nuclear-cytoplasmic shuttling of the Mss4 lipid kinase. EMBO J 2003;22:4223-4236 (Pubitemid 37021750)